HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fredrik Erlandsson Selected Research

verinurad

1/2022Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia.
1/2021In Vitro Assessment of the Drug-Drug Interaction Potential of Verinurad and Its Metabolites as Substrates and Inhibitors of Metabolizing Enzymes and Drug Transporters.
1/2021Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial.
1/2021Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fredrik Erlandsson Research Topics

Disease

4Neoplasms (Cancer)
02/2014 - 09/2004
3Chronic Renal Insufficiency
01/2022 - 12/2020
2Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2021
2Albuminuria
01/2022 - 01/2021
2Hyperuricemia
01/2021 - 01/2021
2Breast Neoplasms (Breast Cancer)
01/2021 - 11/2011
2Renal Cell Carcinoma (Grawitz Tumor)
02/2014 - 04/2011
1Heart Failure
01/2021
1Ulcerative Colitis
10/2018
1Inflammation (Inflammations)
10/2018
1Disease Progression
11/2011
1Melanoma (Melanoma, Malignant)
04/2011
1Fatigue
04/2011
1Necrosis
11/2008
1Rhabdomyosarcoma
11/2008
1Sarcoma (Soft Tissue Sarcoma)
11/2008
1Ewing Sarcoma (Sarcoma, Ewing)
11/2008
1Synovial Sarcoma (Synovioma)
11/2008
1Retinoblastoma (Glioblastoma, Retinal)
05/2005
1Chromosomal Instability (Chromosome Stability)
09/2004
1Uterine Cervical Dysplasia
09/2004
1Carcinogenesis
09/2004
1Carcinoma (Carcinomatosis)
04/2003
1Cri-du-Chat Syndrome (5p- Syndrome)
04/2003

Drug/Important Bio-Agent (IBA)

4verinuradIBA
01/2022 - 01/2021
4Uric Acid (Urate)IBA
01/2022 - 01/2021
3FebuxostatFDA Link
01/2022 - 01/2021
3Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2011
2CytokinesIBA
10/2018 - 04/2011
2Telomerase (Telomerase Reverse Transcriptase)IBA
09/2004 - 04/2003
1Aluminum Oxide (Sapphire)IBA
01/2022
1AlbuminsIBA
01/2022
1Allopurinol (Remid)FDA LinkGeneric
01/2022
1CreatinineIBA
01/2022
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2021
1dapagliflozinIBA
01/2021
1QuartzIBA
01/2021
1Organic Anion TransportersIBA
01/2021
1Xanthine OxidaseIBA
01/2021
1RNA (Ribonucleic Acid)IBA
12/2020
1MicroRNAs (MicroRNA)IBA
10/2018
1Thymic Stromal LymphopoietinIBA
10/2018
1Tyrosine Kinase InhibitorsIBA
02/2014
1AGRO 100IBA
02/2014
1NucleolinIBA
02/2014
1A-Form DNA (A-DNA)IBA
02/2014
1Nucleotide AptamersIBA
02/2014
1Letrozole (Femara)FDA LinkGeneric
11/2011
1AntigensIBA
11/2011
1Estrogen ReceptorsIBA
11/2011
1Immunoglobulins (Immunoglobulin)IBA
11/2011
1Hormones (Hormone)IBA
11/2011
1Estrogens (Estrogen)FDA Link
11/2011
1epitumomabIBA
11/2011
1Biomarkers (Surrogate Marker)IBA
04/2011
1Transaminases (Aminotransferases)IBA
04/2011
1Interleukin-12 (IL 12)IBA
04/2011
1Fibronectins (Fibronectin)IBA
04/2011
1InterferonsIBA
04/2011
1LigandsIBA
11/2008
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2008
1Sorafenib (BAY 43-9006)FDA Link
11/2008
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2008
1Insulin (Novolin)FDA Link
11/2008
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
05/2005
1Cyclin EIBA
04/2003
1chenodeoxycholate sulfate conjugate (CDCS)IBA
04/2003

Therapy/Procedure

3Therapeutics
01/2021 - 11/2008